Literature DB >> 3675730

On the mode of action of six putative dopamine receptor agonists on suppression of exploratory behaviour in rats.

L Ståhle, U Ungerstedt.   

Abstract

The effects of six putative dopamine receptor agonists on exploratory behaviour in rats were assessed: pergolide, (+)- and (-)-3-PPP, bromocriptine, mesulergine and CQ 32-084. Behaviour was automatically recorded in a holeboard apparatus and the data were analysed by the novel multivariate statistical method of partial least squares. All six substances suppressed exploratory behaviour at low doses. Pergolide and (+)-3-PPP-induced stereo-typed behaviour at higher doses. The suppression of exploration induced by pergolide was completely antagonised by sulpiride, partly antagonised by metoclopramide and weakly affected by haloperidol pretreatment. The effects of a low dose of (+)-3-PPP, bromocriptine or CQ 32-084, but not (-)-3-PPP or mesulergine, were antagonised by sulpiride. These findings support the hypotheses that pergolide, (+)-3-PPP, bromocriptine and CQ 32-084 inhibit exploration via stimulation of dopamine receptors. The present data do not substantiate the hypothesis that the suppression of exploration induced by (-)-3-PPP is mediated by stimulation of dopamine autoreceptors. A detailed analysis of the dose curves for pergolide and (+)-3-PPP indicates that the latter compound may have effects in addition to those of a dopamine receptor agonist.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3675730     DOI: 10.1007/bf00217053

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  31 in total

1.  Evidence for dopamine receptors in the human brain mediating sedation and sleep.

Authors:  G U Corsini; M Del Zompo; S Manconi; M P Piccardi; P L Onali; A Mangoni
Journal:  Life Sci       Date:  1977-05-01       Impact factor: 5.037

2.  Effects of (8beta)-8-[methylthio)methyl]-6-propylergoline on dopaminergic function and brain dopamine turnover in rats.

Authors:  R W Fuller; J A Clemens; E C Kornfeld; H D Snoddy; E B Smalstig; N J Bach
Journal:  Life Sci       Date:  1979-01-22       Impact factor: 5.037

3.  Interaction of ergot drugs with central monoamine systems. Evidence for a high potential in the treatment of mental and neurological disorders.

Authors:  K Fuxe; B B Fredholm; L F Agnati; S O Ogren; B J Everitt; G Jonsson; J A Gustafsson
Journal:  Pharmacology       Date:  1978       Impact factor: 2.547

Review 4.  Effect of apomorphine on schizophrenic symptoms.

Authors:  R C Smith; C Tamminga; J M Davis
Journal:  J Neural Transm       Date:  1977       Impact factor: 3.575

5.  Mesulergine and its 1,20-N,N-bidemethylated metabolite interact directly with D1- and D2-receptors.

Authors:  R Markstein
Journal:  Eur J Pharmacol       Date:  1983-11-11       Impact factor: 4.432

6.  Characterization of normal and supersensitive dopamine receptors: effects of ergot drugs and neuropeptides.

Authors:  K Fuxe; L F Agnati; C Köhler; D Kuonen; S O Ogren; K Andersson; T Hökfelt
Journal:  J Neural Transm       Date:  1981       Impact factor: 3.575

7.  The 'presynaptic' blocking potency of sulpiride and haloperidol in the rat is age-dependent.

Authors:  S O Ogren; A Rodebjer; K Angeby
Journal:  Neurosci Lett       Date:  1984-05-04       Impact factor: 3.046

8.  Interactions of ergot alkaloids with anterior pituitary D-2 dopamine receptors.

Authors:  D R Sibley; I Creese
Journal:  Mol Pharmacol       Date:  1983-05       Impact factor: 4.436

9.  Two novel prolactin release-inhibiting 8 alpha-amino-ergolines.

Authors:  E Flückiger; U Briner; H R Bürki; P Marbach; H R Wagner; W Doepfner
Journal:  Experientia       Date:  1979-12-15

10.  Catecholamine receptor agonists: effects on motor activity and rate of tyrosine hydroxylation in mouse brain.

Authors:  U Strömbom
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1976       Impact factor: 3.000

View more
  5 in total

1.  On the selectivity and specificity of the antagonism of apomorphine-induced suppression of exploration by sulpiride.

Authors:  L Ståhle; U Ungerstedt
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

2.  Effects of low, autoreceptor selective doses of dopamine agonists on the discriminative cue and locomotor hyperactivity produced by d-amphetamine.

Authors:  L Furmidge; Z Y Tong; N Petry; D Clark
Journal:  J Neural Transm Gen Sect       Date:  1991

3.  Sedative and anxiolytic effects of the extracts of the leaves of Stachytarpheta cayennensis in mice.

Authors:  Gbola Olayiwola; Otas Ukponmwan; Dayo Olawode
Journal:  Afr J Tradit Complement Altern Med       Date:  2013-10-03

4.  A 1H magnetic resonance spectroscopy study in adults with obsessive compulsive disorder: relationship between metabolite concentrations and symptom severity.

Authors:  Göran Starck; Maria Ljungberg; Marie Nilsson; Lars Jönsson; Stefan Lundberg; Tord Ivarsson; Susanne Ribbelin; Sven Ekholm; Arvid Carlsson; Eva Forssell-Aronsson; Maria L Carlsson
Journal:  J Neural Transm (Vienna)       Date:  2008-06-05       Impact factor: 3.575

5.  Apomorphine-induced yawning in rats is abolished by bilateral 6-hydroxydopamine lesions of the substantia nigra.

Authors:  A J Stoessl; C T Dourish; S D Iversen
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.